Proposed
Resolution · 119th Congress · HRES 685
Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.
Refreshed 6 h ago
Introduced 2025-09-09Topic: health care · public healthSummary
AI-generated summary, report an errorThis resolution states that the House of Representatives supports testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening. APS is a condition in which the immune system makes antibodies that raise the risk of blood clots and pregnancy loss. The resolution notes that medical groups currently recommend APS testing only after certain unexplained pregnancy losses. It calls on professional medical associations and guideline-setting bodies to update their recommendations to include APS testing in standard prenatal screening. The resolution does not create a legal requirement or provide funding.
Sponsors
- Kat Cammack Republican sponsor
- 7 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2025-09-09 | House | Referred to the House Committee on Energy and Commerce. | refer |
| 2025-09-09 | Submitted in House | refer | |
| 2025-09-09 | Submitted in House | introduce |